Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Galileo, OpenAI, and 370+ companies. 5-min read every Tuesday.
Galileo builds AI systems for healthcare diagnostics, developing foundation models that can read medical images, pathology slides, and clinical notes to assist physicians in making faster, more accurate diagnoses. Valued at 220M USD with 70M raised, Galileo serves major health systems and competes with Google Health and Tempus in the 100B+ AI healthcare diagnostics market.
| Industry | Artificial Intelligence |
| Stage | Series A |
| IPO Status | Private |
| Valuation | $220M |
| Total Funding | $90M |
| Headquarters | San Francisco, CA |
OpenAI is valued at $852B — the world's most valuable AI company, backed by $27B in funding. Track IPO readiness score, funding rounds, and timeline.
| Industry | Artificial Intelligence |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $852B |
| Total Funding | $55.4B |
| Headquarters | San Francisco, CA |
Galileo is valued at $220M. OpenAI is valued at $852B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
Galileo has raised $90M. OpenAI has raised $55.4B.
Galileo is currently private. OpenAI is currently pre-IPO. Track both on TechStackIPO for S-1 filings and IPO announcements.
Galileo operates in Artificial Intelligence, while OpenAI operates in Artificial Intelligence.
Galileo is a Artificial Intelligence company valued at $220M with $90M raised. OpenAI is a Artificial Intelligence company valued at $852B with $55.4B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in Galileo and OpenAI through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.